share_log

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director KANTOFF AARON

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities

Avalo Therapeutics | 3:首次持股聲明
SEC announcement ·  04/03 16:04
Moomoo AI 已提取核心訊息
Aaron Kantoff, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, indicates that Kantoff does not beneficially own any non-derivative or derivative securities of the company. The filing is a routine disclosure required by the Securities Exchange Act of 1934 and the Investment Company Act of 1940, which mandates insiders to report their securities holdings in the company. The address listed for Kantoff is c/o Avalo Therapeutics, Inc. at 540 Gaither Road, Suite 400, Rockville, MD, 20850.
Aaron Kantoff, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, indicates that Kantoff does not beneficially own any non-derivative or derivative securities of the company. The filing is a routine disclosure required by the Securities Exchange Act of 1934 and the Investment Company Act of 1940, which mandates insiders to report their securities holdings in the company. The address listed for Kantoff is c/o Avalo Therapeutics, Inc. at 540 Gaither Road, Suite 400, Rockville, MD, 20850.
根據2024年3月28日提交的表格3,Avalo Therapeutics, Inc. 的董事兼10%所有者亞倫·坎托夫已向美國證券交易委員會提交了初步的證券實益擁有權聲明。該表格於2024年4月3日簽署,表明坎托夫不以實益方式擁有該公司的任何非衍生或衍生證券。該文件是1934年《證券交易法》和1940年《投資公司法》要求的例行披露,後者要求內部人士報告其持有的公司證券。坎托夫列出的地址是位於馬里蘭州羅克維爾蓋瑟路540號400號20850號Avalo Therapeutics, Inc.的 c/o Avalo Therapeutics, Inc.
根據2024年3月28日提交的表格3,Avalo Therapeutics, Inc. 的董事兼10%所有者亞倫·坎托夫已向美國證券交易委員會提交了初步的證券實益擁有權聲明。該表格於2024年4月3日簽署,表明坎托夫不以實益方式擁有該公司的任何非衍生或衍生證券。該文件是1934年《證券交易法》和1940年《投資公司法》要求的例行披露,後者要求內部人士報告其持有的公司證券。坎托夫列出的地址是位於馬里蘭州羅克維爾蓋瑟路540號400號20850號Avalo Therapeutics, Inc.的 c/o Avalo Therapeutics, Inc.
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息